Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

A Scherpereel, P Astoul, P Baas… - European …, 2010 - Eur Respiratory Soc
Malignant pleural mesothelioma (MPM) is a rare tumour but with increasing incidence and a
poor prognosis. In 2008, the European Respiratory Society/European Society of Thoracic …

ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax

JM Tschopp, O Bintcliffe, P Astoul… - European …, 2015 - Eur Respiratory Soc
Primary spontaneous pneumothorax (PSP) affects young healthy people with a significant
recurrence rate. Recent advances in treatment have been variably implemented in clinical …

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma

…, M Glatzer, D Rigau, P Astoul… - European respiratory …, 2020 - Eur Respiratory Soc
The European Respiratory Society (ERS)/European Society of Thoracic Surgeons (ESTS)/European
Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Thoracoscopic talc poudrage pleurodesis for malignant effusions: a review of 360 cases

JR Viallat, F Rey, P Astoul, C Boutin - Chest, 1996 - Elsevier
Objective To assess the efficacy, permanence, and safety of thoracoscopic talc poudrage (TTP)
for pleurodesis in malignant effusions. Design Retrospective. Participants Patients with …

The French national mesothelioma surveillance program

…, C Boutin, G Launoy, JC Pairon, P Astoul… - Occupational and …, 2006 - oem.bmj.com
Objectives: The French National Mesothelioma Surveillance Program (NMSP) was
established in 1998 by the National Institute for Health Surveillance (InVS). Its objectives are to …

[HTML][HTML] Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management

…, AM Tasei, C Doddoli, R Giudicelli, P Astoul… - The Journal of thoracic …, 2007 - Elsevier
OBJECTIVE: No guidelines detailing recommendations for the selection and treatment of
patients with synchronous multiple primary lung cancer have been published. We report on a …

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

…, P Chanez, L GREILLIER, P ASTOUL… - The Lancet …, 2020 - thelancet.com
Background Lung cancer screening with low-dose chest CT (LDCT) reduces the mortality of
eligible individuals. Blood signatures might act as a standalone screening tool, refine the …

Intrapleural administration of interleukin‐2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study

P Astoul, D Picat‐Joossen, JR Viallat… - … International Journal of …, 1998 - Wiley Online Library
BACKGROUND The prognosis associated with malignant pleural mesothelioma (MPM) is
poor in spite of surgery, radiotherapy, photodynamic therapy, or chemotherapy. Therefore, …

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma

…, I Psallidas, M Glatzer, D Rigau, P Astoul… - European journal of …, 2020 - academic.oup.com
The European Respiratory Society (ERS)/European Society of Thoracic Surgeons (ESTS)/European
Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study

…, CH Marquette, M Noppen, P Astoul… - European …, 2011 - Eur Respiratory Soc
The safety of talc pleurodesis is under dispute following reports of talc-induced acute respiratory
distress syndrome (ARDS) and death. We investigated the safety of large-particle talc …